Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5;24(7):6784.
doi: 10.3390/ijms24076784.

MC-PRPA-HLFIA Cascade Detection System for Point-of-Care Testing Pan-Drug-Resistant Genes in Urinary Tract Infection Samples

Jin Tao  1 , Dejun Liu  1 , Jincheng Xiong  1 , Wenchong Shan  1 , Leina Dou  1 , Weishuai Zhai  1 , Yang Wang  1 , Jianzhong Shen  1 , Kai Wen  1
Affiliations

MC-PRPA-HLFIA Cascade Detection System for Point-of-Care Testing Pan-Drug-Resistant Genes in Urinary Tract Infection Samples

Jin Tao et al. Int J Mol Sci. .

Abstract

Recently, urinary tract infection (UTI) triggered by bacteria carrying pan-drug-resistant genes, including carbapenem resistance gene blaNDM and blaKPC, colistin resistance gene mcr-1, and tet(X) for tigecycline resistance, have been reported, posing a serious challenge to the treatment of clinical UTI. Therefore, point-of-care (POC) detection of these genes in UTI samples without the need for pre-culturing is urgently needed. Based on PEG 200-enhanced recombinase polymerase amplification (RPA) and a refined Chelex-100 lysis method with HRP-catalyzed lateral flow immunoassay (LFIA), we developed an MCL-PRPA-HLFIA cascade assay system for detecting these genes in UTI samples. The refined Chelex-100 lysis method extracts target DNA from UTI samples in 20 min without high-speed centrifugation or pre-incubation of urine samples. Following optimization, the cascade detection system achieved an LOD of 102 CFU/mL with satisfactory specificity and could detect these genes in both simulated and actual UTI samples. It takes less than an hour to complete the process without the use of high-speed centrifuges or other specialized equipment, such as PCR amplifiers. The MCL-PRPA-HLFIA cascade assay system provides new ideas for the construction of rapid detection methods for pan-drug-resistant genes in clinical UTI samples and provides the necessary medication guidance for UTI treatment.

Keywords: Chelex-100; extensively drug-resistant genes; lateral flow immunoassay; recombinase polymerase amplification; urinary tract infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Scheme of the cascade detection system. (A) Schematic illustration of RPA, (B) HRP-catalyzed LFIA.
Figure 2
Figure 2
Feasibility of bacterial DNA extraction from uncultured bacterial-containing urine samples by refined Chelex-100 lysis method. (A) DNA concentration, (B) OD260/OD280 value, (C) OD260/OD230 value.
Figure 3
Figure 3
Comparison of the refined Chelex-100 lysis method with commercial kits applied in cultured bacterial-containing urine. (A) concentration of DNA, (B) OD260/OD280 value, (C) OD260/OD230 value.
Figure 4
Figure 4
Sensitivity for detecting pan-drug-resistant genes in urine samples. Linear regression and actual images. (A) mcr-1, (B) blaNDM, (C) blaKPC, (D) tet(X3), (E) tet(X4), (F) tet(X5), (G) tet(X6). NC, negative control.
Figure 5
Figure 5
Specificity analysis for pan-drug-resistant genes testing in urine samples. (A) mcr-1, (B) blaNDM, (C) blaKPC, (D) tet(X). NC, negative control.
See this image and copyright information in PMC

References

    1. Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010;7:653–660. doi: 10.1038/nrurol.2010.190. - DOI - PubMed
    1. Cai T., Nesi G., Mazzoli S., Meacci F., Lanzafame P., Caciagli P., Mereu L., Tateo S., Malossini G., Selli C., et al. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin. Infect. Dis. 2015;61:1655–1661. doi: 10.1093/cid/civ696. - DOI - PubMed
    1. Potter R.F., D’Souza A.W., Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug. Resist. Update. 2016;29:30–46. doi: 10.1016/j.drup.2016.09.002. - DOI - PMC - PubMed
    1. Liu Y.Y., Wang Y., Walsh T.R., Yi L.X., Zhang R., Spencer J., Doi Y., Tian G., Dong B., Huang X., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect. Dis. 2016;16:161–168. doi: 10.1016/S1473-3099(15)00424-7. - DOI - PubMed
    1. Liu D., Zhai W., Song H., Fu Y., Schwarz S., He T., Bai L., Wang Y., Walsh T.R., Shen J. Identification of the novel tigecycline resistance gene tet(X6) and its variants in Myroides, Acinetobacter and Proteus of food animal origin. J. Antimicrob. Chemother. 2020;75:1428–1431. doi: 10.1093/jac/dkaa037. - DOI - PubMed